ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

October 31, 2014

Committee Unblinds Phase III Zytiga Study

March 30, 2012

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003

Reviewers Found For Chronobiolgy

June 30, 1989

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980

FCRC Preproposal Conference Draws 36 Institutions

August 14, 1981